Genetic aspects of the antiphospholipid syndrome: An update

Autoimmunity Reviews

Volumn 15, Issue 5, 2016, Pages 433-439

  Sebastiani, Gian Domenico ^a   Iuliano, Annamaria ^a   Cantarini, Luca ^b   Galeazzi, Mauro ^b  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Antiphospholipid syndrome; HLA; Immunogenetics; MHC; Thrombophilic hereditary factors

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; CARDIOLIPIN ANTIBODY; HLA ANTIGEN; INTERFERON REGULATORY FACTOR 5; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PROTHROMBIN; STAT4 PROTEIN; ANTIBODY;

ALLELE; ANTIPHOSPHOLIPID SYNDROME; DISEASE PREDISPOSITION; DNA POLYMORPHISM; GENETIC PREDISPOSITION; HLA SYSTEM; HUMAN; IMMUNOGENETICS; META ANALYSIS (TOPIC); NONHUMAN; PATHOGENESIS; POPULATION RESEARCH; REVIEW; THROMBOPHILIA; TRANSCRIPTION REGULATION; ANIMAL; GENETIC POLYMORPHISM; GENETICS; IMMUNOLOGY; PROTEIN PROCESSING;

ANIMALS; ANTIBODIES; ANTIPHOSPHOLIPID SYNDROME; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84959066893     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2016.01.005     Document Type: Review

References (43)

1. Lulli P., Sebastiani G.D., Trabace S., Passiu G., Cappellacci S., Porzio F., et al. HLA antigens in Italian patients with systemic lupus erythematosus: evidence for the association of DQw2 with the autoantibody response to extractable nuclear antigens. Clin Exp Rheumatol 1991, 9:475-479.
2. Gharavi A.E., Mellors R.C., Elkon K.B. IgG anti-cardiolipin antibodies in murine lupus. Clin Exp Immunol 1989, 78:223-238.
3. Hashimoto Y., Kawamura M., Ichikawa K., Suzuki T., Sumida T., Yoshida S., et al. Anticardiolipin antibodies in NZW × BXSB F1 mice. A model of antiphospholipid syndrome. J Immunol 1992, 149:1063-1068.
4. Ansar Ahmed S., Verthelyi D. Antibodies to cardiolipin in normal C57BL/6J mice: induction by estrogen but not dihydrotestosterone. J Autoimm 1993, 6:265-279.
5. Ida A., Hirose S., Hamano Y., Kodera S., Jiang Y., Abe M., et al. Multigenic control of lupus-associated antiphospholipid syndrome in a model of (NZW × BXSB)F1 mice. Eur J Immunol 1998, 28:2694-2703.
6. Exner T., Barber S., Kronenberg H., Rickard K.A. Familial association of the lupus anticoagulant. Br J Haematol 1980, 45:89-96.
7. Matthey F., Walshe K., Mackie I.J., Machin S.J. Familial occurrence of the antiphospholipid syndrome. J Clin Pathol 1989, 42:495-497.
8. Jolidon R.-M., Knecht H., Humair L., de Torrente A. Different clinical manifestations of a lupus anticoagulant in the same family. Klin Wochenschr 1991, 69:340-344.
9. Dagenais P., Urowitz M.B., Gladman D.D., Norman C.S. A family study of the antiphospholipid syndrome associated with other autoimmune diseases. J Rheumatol 1992, 19:1393-1396.
10. Rouget J.P., Goudemand J., Montreuil G., Cosson A., Jaillard J. Lupus anticoagulant: a familial observation. Lancet 1982, 2:105.
11. Mackie I.J., Colaco C.B., Machin S.J. Familial lupus anticoagulants. Br J Haematol 1987, 67:359-363.
12. May K.P., West S.G., Moulds J., Kotzin B.L. Different manifestations of the antiphospholipid antibody syndrome in a family with systemic lupus erythematosus. Arthritis Rheum 1993, 36:528-533.
13. Arnett F.C., Olsen M.L., Anderson K.L., Reveille J.D. Molecular analysis of major histocompatibility complex alleles associated with the lupus anticoagulant. J Clin Invest 1991, 87:1490.
14. Asherson R.A., Doherty D.G., Vergani D., Khamashta M.A., Hughes G.R.V. Concise communication: major histocompatibility complex associations with primary antiphospholipid syndrome. Arthritis Rheum 1992, 35:124-125.
15. Caliz R., Atsumi T., Kondeatis E., Amengual O., Khamashta M.A., Vaughan R.W., et al. HLA class II gene polymorphisms in antiphospholipid syndrome: haplotype analysis in 83 Caucasoid patients. Rheumatology 2001, 40:31-36.
16. Bertolaccini M.L., Atsumi T., Caliz A.R., Amengual O., Khamashta M.A., Hughes G.R.V., et al. Association of antiphosphatidylserine/prothrombin autoantibodies with HLA class II genes. Arthritis Rheum 2000, 43:683-688.
17. Bertolaccini M.L., Atsumi T., Lanchbury J.S., Caliz A.R., Katsumata K., Vaughan R.W., et al. Plasma tumor necrosis factor alpha levels and the -238*A promoter polymorphism in patients with antiphospholipid syndrome. Thromb Haemost 2001, 85:198-203.
18. Vargas-Alarcon G., Granados J., Bekker C., Alcocer-Varela J., Alarcon-Segovia D. Association of HLA-DR5 (possibly DRB1*1201) with the primary antiphospholipid syndrome in Mexican patients. Arthritis Rheum 1995, 38:1340-1341.
19. Freitas M.V., da Silva L.M., Deghaide N.H., Donadi E.A., Louzada-Júnior P. Is HLA class II susceptibility to primary antiphospholipid syndrome different from susceptibility to secondary antiphospholipid syndrome?. Lupus 2004, 13:125-131.
20. Sanchez M.L., Katsumata K., Atsumi T., Romero F.I., Bertolaccini M.L., Funke A., et al. Association of HLA-DM polymorphism with the production of antiphospholipid antibodies. Ann Rheum Dis 2004, 63:1645-1648.
21. Al Attia H.M., Santosh A., Al Farhan M.M. Observations on class II antigens and genetic susceptibility to primary antiphospholipid (Hughes) syndrome in Arab patients. Clin Exp Rheumatol 2008, 26:506.
22. Relle M., Weinmann-Menke J., Scorletti E., Cavagna L., Schwarting A. Genetics and novel aspects of therapies in systemic lupus erythematosus. Autoimmun Rev 2015 Nov, 14(11):1005-1018.
23. Galeazzi M., Sebastiani G.D., Tincani A., Piette J.C., Allegri F., Morozzi G., et al. HLA class II associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Lupus 2000, 9:47-55.
24. Sebastiani G.D., Galeazzi M., Tincani A., Scorza R., Mathieu A., Passiu G., et al. European concerted action on immunogenetics of SLE. HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with SLE. Lupus 2003, 12:560-563.
25. Sebastiani G.D., Morozzi G., Bellisai F., Fineschi I., Bacarelli M.R., Simpatico A., et al. Anti-cofactor autoantibodies in systemic lupus erythematosus: prevalence, clinical and HLA class II associations. Immunol Invest 2008, 37:375-385.
26. Arnett F.C., Thiagarajan P., Ahn C., Reveille J.D. Associations of anti-beta2-glycoprotein I autoantibodies with HLA class II alleles in three ethnic groups. Arthritis Rheum 1999, 42:268-274.
27. Tiwari J.H., Terasaki P.I. Connective tissue diseases. HLA and disease associations 1985, 363-369. Springer-Verlag, New York.
28. H1 Yin, MO Borghi, AM Delgado-Vega, Tincani A., PL Meroni, ME Alarcón-Riquelme Association of STAT4 and BLK, but not BANK1 or IRF5, with primary antiphospholipid syndrome. Arthritis Rheum 2009, 60:2468-2471.
29. Fredi M., Tincani A., Yin H., Delgado-Vega A.M., Borghi M.O., Meroni P.L., et al. IRF5 is associated with primary antiphospholipid syndrome, but is not a major risk factor. Arthritis Rheum 2010, 62:1201-1202.
30. Xie H., Kong X., Zhou H., Xie Y., Sheng L., Wang T., et al. TLR4 is involved in the pathogenic effects observed in a murine model of antiphospholipid syndrome. Clin Immunol 2015, 160:198-210.
31. Pierangeli S.S., Vega-Ostertag M.E., Raschi E., Liu X., Romay-Penabad Z., De Micheli V., et al. Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies. Ann Rheum Dis 2007, 66:1327-1333.
32. Ochoa E., Iriondo M., Bielsa A., Ruiz-Irastorza G., Estonba A., Zubiaga A.M. Thrombotic antiphospholipid syndrome shows strong haplotypic association with SH2B3-ATXN2locus. PLoS One 2013, 3.
33. Bottini N., Vang T., Cucca F., Mustelin T. Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Semin Immunol 2006, 18:207-213.
34. J1 Castro-Marrero, Balada E., Vilardell-Tarrés M., Ordi-Ros J. The PTPN22*R620W polymorphism does not confer genetic susceptibility to antiphospholipid syndrome in the Spanish population. Int J Immunogenet 2011, 38:529-531.
35. Hirose N., Williams R., Alberts A.R., Furie R.A., Chartash E.K., Jain R.I., et al. A role for the polymorphism at position 247 of the beta2-glycoprotein I gene in the generation of anti-beta2-glycoprotein I antibodies in the antiphospholipid syndrome. Arthritis Rheum 1999, 42:1655-1661.
36. YH1 Lee, SJ Choi, JD Ji, GG Song Association between the valine/leucine247 polymorphism of β2-glycoprotein I and susceptibility to anti-phospholipid syndrome: a meta-analysis. Lupus 2012, 21:865-871.
37. H1 Berman, MF Ugarte-Gil, Espinosa G., Tàssies D., Monteagudo J., JC Reverter, et al. Can inherited thrombophilia modulate the clinical phenotype of patients with antiphospholipid syndrome?. Clin Exp Rheumatol 2013, 31:926-932.
38. Pretorius E., Vermeulen N., Bester J. Atypical erythrocytes and platelets in a patient with a pro-thrombin mutation. Platelets 2014, 25:461-462.
39. Ames P.R., Margaglione M., Tommasino C., Bossone A., Iannaccone L., Brancaccio V. Impact of plasma homocysteine and prothrombin G20210 A on primary antiphospholipid syndrome. Blood Coagul Fibrinolysis 2001, 12:699-704.
40. Fickentscher C., Magorivska I., Janko C., Biermann M., Bilyy R., Nalli C., et al. The pathogenicity of anti-β2GP1-IgG autoantibodies depends on Fc glycosylation. J Immunol Res 2015, 2015:638129. Epub 2015 Jun 22. 10.1155/2015/638129.
41. FH1 Passam, Giannakopoulos B., Mirarabshahi P., SA Krilis Molecular pathophysiology of the antiphospholipid syndrome: the role of oxidative post-translational modification of beta 2 glycoprotein I. J Thromb Haemost 2011, 9:275-282. Jul.
42. Mackern-Oberti J.P., Llanos C., Vega F., Salazar-Onfray F., Riedel C.A., Bueno S.M., et al. Role of dendritic cells in the initiation, progress and modulation of systemic autoimmune diseases. Autoimmun Rev 2015 Feb, 14(2):127-139.
43. Zhang Z., Zhang R. Epigenetics in autoimmune diseases: pathogenesis and prospects for therapy. Autoimmun Rev 2015 Oct, 14(10):854-863.